No abstract
Acta Diabetol. 2025 Mar 19. doi: 10.1007/s00592-025-02482-7. Online ahead of print.
NO ABSTRACT
PMID:40105914 | DOI:10.1007/s00592-025-02482-7
Correction: Different formulations of semaglutide and oxidative stress in subjects with type 2 diabetes and MASLD: an open-label, real-life study
Scritto il 19/03/2025
da Giovanni Petralli